Theophylline 24-Hour Extended Release Capsules and Tablets Shortage
Last Updated: April 5, 2024
Status: Current
Products Affected - Description
-
- Theo-24 extended release capsule, Endo Pharmaceuticals, 300 mg, bottle, 100 count, NDC 52244-0300-10
- Theophylline extended release tablet, Rhodes, 400 mg, bottle, 100 count, NDC 42858-0701-01
- Theophylline extended release tablet, Rhodes, 600 mg, bottle, 100 count, NDC 42858-0702-01
Reason for the Shortage
-
- Endo did not provide a reason for the shortage.
- Rhodes did not provide a reason for the shortage.
- Glenmark has theophylline 24-hour extended-release tablets available. The company is reviewing orders.
Available Products
-
- Theo-24 extended release capsule, Endo Pharmaceuticals, 100 mg, bottle, 100 count, NDC 52244-0100-10
- Theo-24 extended release capsule, Endo Pharmaceuticals, 200 mg, bottle, 100 count, NDC 52244-0200-10
- Theo-24 extended release capsule, Endo Pharmaceuticals, 400 mg, bottle, 100 count, NDC 52244-0400-10
- Theophylline extended release tablet, Glenmark, 400 mg, bottle, 100 count, NDC 68462-0380-01
- Theophylline extended release tablet, Glenmark, 600 mg, bottle, 100 count, NDC 68462-0356-01
Estimated Resupply Dates
-
- Rhodes has all presentations on back order and the company cannot estimate a release date.
- Endo has Theo-24 300 mg extended-release capsules on back order and the company cannot estimate a release date.
Updated
Updated April 5, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created August 22, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.